Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics

22 Dec 2021

Abstract excerpt

Teicoplanin is a natural lipoglycopeptide antibiotic with a similar activity spectrum as vancomycin; however, it has with the added benefit to the patient of low cytotoxicity. Both teicoplanin and vancomycin antibiotics are actively used in medical practice in the prophylaxis and treatment of severe life-threatening infections caused by gram-positive bacteria, including methicillin-resistant Staphylococcus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antimicrobial Resistance in Staphylococcus
Share to Biochemical and Structural Characterization

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35008521
DOI: 10.3390/ijms23010097

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide AntibioticsPMID 35008521Read ↗

VanZ Reduces the Binding of Lipoglycopeptide Antibiotics to Staphylococcus aureus and Streptococcus pneumoniae CellsSemantic proximity Read ↗

Old and New Glycopeptide Antibiotics: Action and ResistanceSemantic proximity Read ↗

A novel membrane protein, VanJ, conferring resistance to teicoplanin.Semantic proximity Read ↗

Understanding the genome-wide response of Streptomyces coelicolor to the glycopeptide antibiotic teicoplaninSemantic proximity Read ↗

Molecular mechanisms of vancomycin resistanceSemantic proximity Read ↗

The Vancomycin Group of Antibiotics and the Fight against Resistant BacteriaSemantic proximity Read ↗

Characterization of VanYn, a novel D,D‐peptidase/D,D‐carboxypeptidase involved in glycopeptide antibiotic resistance in Nonomuraea sp. ATCC 39727Semantic proximity Read ↗

From Vancomycin to Oritavancin: The Discovery and Development of a Novel Lipoglycopeptide AntibioticSemantic proximity Read ↗

Resistance to Glycopeptide Antibiotics in the Teicoplanin Producer Is Mediated by <i>van</i> Gene Homologue Expression Directing the Synthesis of a Modified Cell Wall PeptidoglycanSemantic proximity Read ↗

Identification of Potential Inhibitors Against Staphylococcus Aureus: In Silico Analysis of the LLM Gene as a Therapeutic TargetSemantic proximity Read ↗

Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolatesSemantic proximity Read ↗

Genomic and expression analysis of the vanG-like gene cluster of Clostridium difficileSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.